The rapid diagnostics from Abbott and SD Biosensor will enable expanded testing in countries that do not have extensive laboratory facilities.
Read More
The acquisition rounds out Qiagen’s portfolio of automated molecular testing solutions based on the proven PCR technology.
Read More
The test is intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B.
Read More
The panel consists of 14 units of a unique human plasma sample drawn from a single donor during a developing SARS-CoV-2 infection.
Read More
Sophisticated agtech labs and equipment could easily be adapted for diagnostic testing and tracing in a human pandemic or epidemic.
Read More